Pura Vida Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Pura Vida Investments’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-163,490	Closed	-$4.53M	–	133
2019 Q4	$4.53M	Buy	+163,490	New	+$3.9M	0.4%	60
2019 Q3	–	Sell	-65,000	Closed	-$2.66M	–	129
2019 Q2	$2.66M	Buy	+65,000	New	+$1.83M	0.4%	74

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Pura Vida Investments's AXNX Position: Q1 2020 in Review

Pura Vida Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2020, closing a stake of 163,490 shares — an estimated $4.53M sold.

Pura Vida Investments first reported a position in AXNX in Q2 2019 and held it in 2 quarters. The position peaked at $4.53M in Q4 2019. 115 funds tracked by Wall St. Rank hold AXNX as of Q1 2020.

Pura Vida Investments reported no remaining Axonics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Pura Vida Investments sold 163,490 Axonics, Inc. Common Stock shares in Q1 2020, an estimated $4.53M.
Pura Vida Investments first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Pura Vida Investments's Axonics, Inc. Common Stock position peaked at $4.53M in Q4 2019.
115 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2020.

Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.